+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Engineered T Cells Market Research Report by Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4989700
  • Report
  • January 2021
  • Region: Global
  • 198 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
The Global Engineered T Cells Market to Grow USD 4,174.97 Million by 2025, at a CAGR of 24.69%

FEATURED COMPANIES

  • Autolus
  • Cell Medica
  • Elli Lilly and Company
  • Gilead
  • Juno Therapeutics, Inc.
  • Novartis AG
The Global Engineered T Cells Market to Grow USD 4,174.97 Million by 2025, at a CAGR of 24.69%



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Engineered T Cells Market is expected to grow from USD 1,385.02 Million in 2020 to USD 4,174.97 Million by the end of 2025.
2. The Global Engineered T Cells Market is expected to grow from EUR 1,214.41 Million in 2020 to EUR 3,660.69 Million by the end of 2025.
3. The Global Engineered T Cells Market is expected to grow from GBP 1,079.61 Million in 2020 to GBP 3,254.36 Million by the end of 2025.
4. The Global Engineered T Cells Market is expected to grow from JPY 147,816.80 Million in 2020 to JPY 445,575.39 Million by the end of 2025.
5. The Global Engineered T Cells Market is expected to grow from AUD 2,011.23 Million in 2020 to AUD 6,062.61 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Engineered T Cells to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Engineered T Cells Market is examined across Chimeric Antigen Receptor (CAR), T Cell Receptor (TCR), and Tumor-Infiltrating Lymphocytes.
  • Based on Application, the Engineered T Cells Market is examined across Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, and Melanoma.
  • Based on End User, the Engineered T Cells Market is examined across Cancer Research Centers, Clinics, and Hospitals.
  • Based on Geography, the Engineered T Cells Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Engineered T Cells Market including Autolus, Bellicum Pharmaceuticals, Inc., Cell Medica, Elli Lilly and Company, Gilead, Juno Therapeutics, Inc., Novartis AG, Oxford BioMedica, Pfizer Inc., and Precision Biosciences.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. the ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Engineered T Cells Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Engineered T Cells Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Engineered T Cells Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Engineered T Cells Market?
4. What is the competitive strategic window for opportunities in the Global Engineered T Cells Market?
5. What are the technology trends and regulatory frameworks in the Global Engineered T Cells Market?
6. What are the modes and strategic moves considered suitable for entering the Global Engineered T Cells Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Autolus
  • Cell Medica
  • Elli Lilly and Company
  • Gilead
  • Juno Therapeutics, Inc.
  • Novartis AG
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Engineered T Cells Market, By Type
6.1. Introduction
6.2. Chimeric Antigen Receptor (CAR)
6.3. T Cell Receptor (TCR)
6.4. Tumor-Infiltrating Lymphocytes

7. Global Engineered T Cells Market, By Application
7.1. Introduction
7.2. Breast Cancer
7.3. Colorectal Cancer
7.4. Leukemia
7.5. Lung Cancer
7.6. Melanoma

8. Global Engineered T Cells Market, By End User
8.1. Introduction
8.2. Cancer Research Centers
8.3. Clinics
8.4. Hospitals

9. Americas Engineered T Cells Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Engineered T Cells Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Engineered T Cells Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Autolus
13.2. Bellicum Pharmaceuticals, Inc.
13.3. Cell Medica
13.4. Elli Lilly and Company
13.5. Gilead
13.6. Juno Therapeutics, Inc.
13.7. Novartis AG
13.8. Oxford BioMedica
13.9. Pfizer Inc.
13.10. Precision Biosciences

14. Appendix
14.1. Discussion Guide

List of Figures
Figure 1. Global Engineered T Cells Market: Research Process
Figure 2. Global Engineered T Cells Market: Research Execution
Figure 3. Global Engineered T Cells Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Engineered T Cells Market Size, by Application, 2020 (USD Million)
Figure 5. Global Engineered T Cells Market Size, by Type, 2020 (USD Million)
Figure 6. Global Engineered T Cells Market Size, by End-user, 2020 (USD Million)
Figure 7. Global Engineered T Cells Market Size, by Geography, 2020 (USD Million)
Figure 8. Global Engineered T Cells Market Size, 2018-2025 (USD Million)
Figure 9. Global Engineered T Cells Market Size, by Geography, 2020 Vs 2025 (%)
Figure 10. Global Engineered T Cells Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 11. Competitive Strategic Window for Global Engineered T Cells Market Size, by Geography, 2025
Figure 12. Global Engineered T Cells Market: Market Dynamics
Figure 13. Global Engineered T Cells Market: Porters Five Forces Analysis
Figure 14. Global Engineered T Cells Market Size, by Type, 2020 Vs 2025 (%)
Figure 15. Global Engineered T Cells Market Size, by Type, 2020 Vs 2025 (USD Million)
Figure 16. Competitive Strategic Window for Global Engineered T Cells Market Size, by Type, 2025
Figure 17. Global Engineered T Cells Market Size, by Chimeric Antigen Receptor (Car), 2020 Vs 2025 (USD Million)
Figure 18. Global Engineered T Cells Market Size, by T Cell Receptor (Tcr), 2020 Vs 2025 (USD Million)
Figure 19. Global Engineered T Cells Market Size, by Tumor-Infiltrating Lymphocytes, 2020 Vs 2025 (USD Million)
Figure 20. Global Engineered T Cells Market Size, by Application, 2020 Vs 2025 (%)
Figure 21. Global Engineered T Cells Market Size, by Application, 2020 Vs 2025 (USD Million)
Figure 22. Competitive Strategic Window for Global Engineered T Cells Market Size, by Application, 2025
Figure 23. Global Engineered T Cells Market Size, by Breast Cancer, 2020 Vs 2025 (USD Million)
Figure 24. Global Engineered T Cells Market Size, by Colorectal Cancer, 2020 Vs 2025 (USD Million)
Figure 25. Global Engineered T Cells Market Size, by Leukemia, 2020 Vs 2025 (USD Million)
Figure 26. Global Engineered T Cells Market Size, by Lung Cancer, 2020 Vs 2025 (USD Million)
Figure 27. Global Engineered T Cells Market Size, by Melanoma, 2020 Vs 2025 (USD Million)
Figure 28. Global Engineered T Cells Market Size, by End-user, 2020 Vs 2025 (%)
Figure 29. Global Engineered T Cells Market Size, by End-user, 2020 Vs 2025 (USD Million)
Figure 30. Competitive Strategic Window for Global Engineered T Cells Market Size, by End-user, 2025
Figure 31. Global Engineered T Cells Market Size, by Cancer Research Centers, 2020 Vs 2025 (USD Million)
Figure 32. Global Engineered T Cells Market Size, by Clinics, 2020 Vs 2025 (USD Million)
Figure 33. Global Engineered T Cells Market Size, by Hospitals, 2020 Vs 2025 (USD Million)
Figure 34. Americas Engineered T Cells Market Size, by Geography, 2020 Vs 2025 (%)
Figure 35. Americas Engineered T Cells Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 36. Competitive Strategic Window for Americas Engineered T Cells Market Size, by Geography, 2025
Figure 37. Argentina Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 38. Brazil Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 39. Canada Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. Mexico Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. United States Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 42. Asia-Pacific Engineered T Cells Market Size, by Geography, 2020 Vs 2025 (%)
Figure 43. Asia-Pacific Engineered T Cells Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 44. Competitive Strategic Window for Asia-Pacific Engineered T Cells Market Size, by Geography, 2025
Figure 45. Australia Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 46. China Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. India Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. Indonesia Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. Japan Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Malaysia Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Philippines Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. South Korea Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Thailand Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Europe, Middle East & Africa Engineered T Cells Market Size, by Geography, 2020 Vs 2025 (%)
Figure 55. Europe, Middle East & Africa Engineered T Cells Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 56. Competitive Strategic Window for Europe, Middle East & Africa Engineered T Cells Market Size, by Geography, 2025
Figure 57. France Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. Germany Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Italy Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Netherlands Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. Qatar Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Russia Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. Saudi Arabia Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. South Africa Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. Spain Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. United Arab Emirates Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. United Kingdom Engineered T Cells Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. Global Engineered T Cells Market: FPNV Positioning Matrix
Figure 69. Global Engineered T Cells Market: Market Share Analysis
Figure 70. Global Engineered T Cells Market: Competitor SWOT Analysis
Figure 71. Competitive Scenario Analysis in Global Engineered T Cells Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Engineered T Cells Market Size, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 3. Global Engineered T Cells Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 4. Global Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 5. Global Engineered T Cells Market Size, by Chimeric Antigen Receptor (Car), by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 6. Global Engineered T Cells Market Size, by T Cell Receptor (Tcr), by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 7. Global Engineered T Cells Market Size, by Tumor-Infiltrating Lymphocytes, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 8. Global Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 9. Global Engineered T Cells Market Size, by Breast Cancer, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 10. Global Engineered T Cells Market Size, by Colorectal Cancer, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 11. Global Engineered T Cells Market Size, by Leukemia, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 12. Global Engineered T Cells Market Size, by Lung Cancer, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 13. Global Engineered T Cells Market Size, by Melanoma, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 14. Global Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 15. Global Engineered T Cells Market Size, by Cancer Research Centers, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 16. Global Engineered T Cells Market Size, by Clinics, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 17. Global Engineered T Cells Market Size, by Hospitals, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 18. Americas Engineered T Cells Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 19. Americas Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 20. Americas Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 21. Americas Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 22. Argentina Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 23. Argentina Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 24. Argentina Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 25. Brazil Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 26. Brazil Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 27. Brazil Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 28. Canada Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 29. Canada Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 30. Canada Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 31. Mexico Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 32. Mexico Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 33. Mexico Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 34. United States Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 35. United States Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 36. United States Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 37. Asia-Pacific Engineered T Cells Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 38. Asia-Pacific Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 39. Asia-Pacific Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 40. Asia-Pacific Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 41. Australia Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 42. Australia Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 43. Australia Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 44. China Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 45. China Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 46. China Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 47. India Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 48. India Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 49. India Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 50. Indonesia Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 51. Indonesia Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 52. Indonesia Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 53. Japan Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 54. Japan Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 55. Japan Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 56. Malaysia Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 57. Malaysia Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 58. Malaysia Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 59. Philippines Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 60. Philippines Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 61. Philippines Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 62. South Korea Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 63. South Korea Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 64. South Korea Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 65. Thailand Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 66. Thailand Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 67. Thailand Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 68. Europe, Middle East & Africa Engineered T Cells Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 69. Europe, Middle East & Africa Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 70. Europe, Middle East & Africa Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 71. Europe, Middle East & Africa Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 72. France Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 73. France Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 74. France Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 75. Germany Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 76. Germany Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 77. Germany Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 78. Italy Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 79. Italy Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 80. Italy Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 81. Netherlands Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 82. Netherlands Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 83. Netherlands Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 84. Qatar Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 85. Qatar Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 86. Qatar Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 87. Russia Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 88. Russia Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 89. Russia Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 90. Saudi Arabia Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 91. Saudi Arabia Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 92. Saudi Arabia Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 93. South Africa Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 94. South Africa Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 95. South Africa Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 96. Spain Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 97. Spain Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 98. Spain Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 99. United Arab Emirates Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 100. United Arab Emirates Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 101. United Arab Emirates Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 102. United Kingdom Engineered T Cells Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 103. United Kingdom Engineered T Cells Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 104. United Kingdom Engineered T Cells Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 105. Global Engineered T Cells Market: Scores
Table 106. Global Engineered T Cells Market: Business Strategy
Table 107. Global Engineered T Cells Market: Product Satisfaction
Table 108. Global Engineered T Cells Market: Ranking
Table 109. Global Engineered T Cells Market: Merger & Acquisition
Table 110. Global Engineered T Cells Market: Agreement, Collaboration, & Partnership
Table 111. Global Engineered T Cells Market: New Product Launch & Enhancement
Table 112. Global Engineered T Cells Market: Investment & Funding
Table 113. Global Engineered T Cells Market: Award, Recognition, & Expansion
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Autolus
  • Bellicum Pharmaceuticals, Inc.
  • Cell Medica
  • Elli Lilly and Company
  • Gilead
  • Juno Therapeutics, Inc.
  • Novartis AG
  • Oxford BioMedica
  • Pfizer Inc.
  • Precision Biosciences
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll